Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 3
1990 7
1991 4
1992 4
1993 3
1994 4
1995 5
1996 1
1997 3
1998 3
1999 4
2000 3
2001 5
2002 5
2003 4
2004 3
2005 8
2006 8
2007 8
2008 15
2009 14
2010 14
2011 11
2012 7
2013 13
2014 23
2015 20
2016 18
2017 15
2018 19
2019 19
2020 33
2021 15
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: blandizzi c. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Pellegrini C, et al. Among authors: blandizzi c. NPJ Parkinsons Dis. 2023 Jun 2;9(1):83. doi: 10.1038/s41531-023-00536-7. NPJ Parkinsons Dis. 2023. PMID: 37268652 Free PMC article. No abstract available.
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: blandizzi c. Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465. Pharmaceuticals (Basel). 2023. PMID: 36986565 Free PMC article.
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Pellegrini C, et al. Among authors: blandizzi c. NPJ Parkinsons Dis. 2022 Jan 12;8(1):9. doi: 10.1038/s41531-021-00263-x. NPJ Parkinsons Dis. 2022. PMID: 35022395 Free PMC article.
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.
Convertino I, Giometto S, Gini R, Cazzato M, Fornili M, Valdiserra G, Cappello E, Ferraro S, Bartolini C, Paoletti O, Tillati S, Baglietto L, Turchetti G, Trieste L, Lorenzoni V, Blandizzi C, Mosca M, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: blandizzi c. J Clin Med. 2021 Dec 8;10(24):5743. doi: 10.3390/jcm10245743. J Clin Med. 2021. PMID: 34945038 Free PMC article.
Donepezil improves vascular function in a mouse model of Alzheimer's disease.
Pellegrini C, D'Antongiovanni V, Fornai M, Duranti E, Baldacci F, Bernardini N, Taddei S, Virdis A, Blandizzi C, Masi S, Antonioli L. Pellegrini C, et al. Among authors: blandizzi c. Pharmacol Res Perspect. 2021 Dec;9(6):e00871. doi: 10.1002/prp2.871. Pharmacol Res Perspect. 2021. PMID: 34713597 Free PMC article.
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases.
Convertino I, Cazzato M, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Tillati S, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: blandizzi c. Sci Rep. 2021 Oct 13;11(1):20314. doi: 10.1038/s41598-021-98321-0. Sci Rep. 2021. PMID: 34645838 Free PMC article.
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
Antonioli L, Pellegrini C, Fornai M, Benvenuti L, D'Antongiovanni V, Colucci R, Bertani L, Di Salvo C, Semeghini G, La Motta C, Giusti L, Zallocco L, Ronci M, Quattrini L, Angelucci F, Coviello V, Oh WK, Ha QTK, Németh ZH, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: blandizzi c. Int J Mol Sci. 2021 Jun 13;22(12):6325. doi: 10.3390/ijms22126325. Int J Mol Sci. 2021. PMID: 34199160 Free PMC article.
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity.
Pellegrini C, Fornai M, Benvenuti L, Colucci R, Caputi V, Palazon-Riquelme P, Giron MC, Nericcio A, Garelli F, D'Antongiovanni V, Segnani C, Ippolito C, Nannipieri M, Lopez-Castejon G, Pelegrin P, Haskó G, Bernardini N, Blandizzi C, Antonioli L. Pellegrini C, et al. Among authors: blandizzi c. Br J Pharmacol. 2021 Oct;178(19):3924-3942. doi: 10.1111/bph.15532. Epub 2021 Jun 24. Br J Pharmacol. 2021. PMID: 34000757 Free article.
290 results